Elisabetta Bolli

792 total citations
28 papers, 574 citations indexed

About

Elisabetta Bolli is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Elisabetta Bolli has authored 28 papers receiving a total of 574 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 10 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Elisabetta Bolli's work include Immunotherapy and Immune Responses (15 papers), Virus-based gene therapy research (5 papers) and Cancer Research and Treatments (5 papers). Elisabetta Bolli is often cited by papers focused on Immunotherapy and Immune Responses (15 papers), Virus-based gene therapy research (5 papers) and Cancer Research and Treatments (5 papers). Elisabetta Bolli collaborates with scholars based in Italy, United States and Sweden. Elisabetta Bolli's co-authors include Federica Cavallo, Laura Conti, Roberto Ruiu, Federica Riccardo, Giuseppina Barutello, Valeria Rolih, Lidia Tarone, Elena Quaglino, Stefania Lanzardo and Maddalena Arigoni and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Elisabetta Bolli

28 papers receiving 567 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elisabetta Bolli Italy 14 271 235 200 105 94 28 574
Valeria Rolih Italy 9 126 0.5× 154 0.7× 115 0.6× 34 0.3× 102 1.1× 10 344
Cathrine Lund Lorentzen Denmark 7 308 1.1× 384 1.6× 299 1.5× 46 0.4× 26 0.3× 11 628
Haruka Nishida Japan 12 205 0.8× 117 0.5× 152 0.8× 128 1.2× 25 0.3× 37 472
Ramziya Kiyamova Russia 13 269 1.0× 81 0.3× 97 0.5× 64 0.6× 119 1.3× 49 527
Joseph O. Humtsoe United States 13 346 1.3× 51 0.2× 129 0.6× 108 1.0× 38 0.4× 18 560
Г. И. Дейчман Russia 14 214 0.8× 160 0.7× 216 1.1× 93 0.9× 33 0.4× 41 554
Wenhao Shen China 14 274 1.0× 56 0.2× 64 0.3× 140 1.3× 52 0.6× 31 471
Jia You China 15 332 1.2× 120 0.5× 84 0.4× 227 2.2× 53 0.6× 32 620
Sam H. Whiting United States 9 153 0.6× 76 0.3× 141 0.7× 109 1.0× 85 0.9× 20 361
Masahiro Nobuhara Japan 14 218 0.8× 76 0.3× 142 0.7× 83 0.8× 92 1.0× 25 597

Countries citing papers authored by Elisabetta Bolli

Since Specialization
Citations

This map shows the geographic impact of Elisabetta Bolli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabetta Bolli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabetta Bolli more than expected).

Fields of papers citing papers by Elisabetta Bolli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisabetta Bolli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabetta Bolli. The network helps show where Elisabetta Bolli may publish in the future.

Co-authorship network of co-authors of Elisabetta Bolli

This figure shows the co-authorship network connecting the top 25 collaborators of Elisabetta Bolli. A scholar is included among the top collaborators of Elisabetta Bolli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabetta Bolli. Elisabetta Bolli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Riccardo, Federica, Laura Conti, Lidia Tarone, et al.. (2024). Cancer vaccines: Target antigens, vaccine platforms and preclinical models. Molecular Aspects of Medicine. 101. 101324–101324. 14 indexed citations
2.
Franceschi, Valentina, et al.. (2024). Cross-Reactive Immune Response of Bovine Coronavirus Spike Glycoprotein to SARS-CoV-2 Variants of Concern. International Journal of Molecular Sciences. 25(21). 11509–11509. 1 indexed citations
3.
Ruiu, Roberto, et al.. (2023). Cystine/glutamate antiporter xCT deficiency reduces metastasis without impairing immune system function in breast cancer mouse models. Journal of Experimental & Clinical Cancer Research. 42(1). 16 indexed citations
4.
Conti, Laura, Valentina Franceschi, Myeon‐Sik Yang, et al.. (2023). Assessment of BoHV-4-based vector vaccine intranasally administered in a hamster challenge model of lung disease. Frontiers in Immunology. 14. 1197649–1197649. 1 indexed citations
5.
Tarone, Lidia, Lorella Maniscalco, Selina Iussich, et al.. (2023). A chimeric human/dog-DNA vaccine against CSPG4 induces immunity with therapeutic potential in comparative preclinical models of osteosarcoma. Molecular Therapy. 31(8). 2342–2359. 14 indexed citations
6.
Riccardo, Federica, Lidia Tarone, Selina Iussich, et al.. (2022). Antigen mimicry as an effective strategy to induce CSPG4-targeted immunity in dogs with oral melanoma: a veterinary trial. Journal for ImmunoTherapy of Cancer. 10(5). e004007–e004007. 14 indexed citations
7.
Barutello, Giuseppina, et al.. (2022). Immunotherapy against the Cystine/Glutamate Antiporter xCT Improves the Efficacy of APR-246 in Preclinical Breast Cancer Models. Biomedicines. 10(11). 2843–2843. 4 indexed citations
8.
Macagno, Marco, Elisabetta Bolli, Federica Riccardo, et al.. (2022). Role of ADCC, CDC, and CDCC in Vaccine-Mediated Protection against Her2 Mammary Carcinogenesis. Biomedicines. 10(2). 230–230. 1 indexed citations
9.
Bolli, Elisabetta, Roberto Ruiu, Giuseppe Ferrauto, et al.. (2022). Toll-like receptor 2 promotes breast cancer progression and resistance to chemotherapy. OncoImmunology. 11(1). 2086752–2086752. 27 indexed citations
10.
Conti, Laura, Elisabetta Bolli, Valentina Franceschi, et al.. (2020). Immunotargeting of the xCT Cystine/Glutamate Antiporter Potentiates the Efficacy of HER2-Targeted Immunotherapies in Breast Cancer. Cancer Immunology Research. 8(8). 1039–1053. 32 indexed citations
11.
Bolli, Elisabetta, et al.. (2020). Toll-Like Receptor 2 at the Crossroad between Cancer Cells, the Immune System, and the Microbiota. International Journal of Molecular Sciences. 21(24). 9418–9418. 62 indexed citations
12.
Rolih, Valeria, Jerri C. Caldeira, Elisabetta Bolli, et al.. (2020). Development of a VLP-Based Vaccine Displaying an xCT Extracellular Domain for the Treatment of Metastatic Breast Cancer. Cancers. 12(6). 1492–1492. 28 indexed citations
13.
Ruiu, Roberto, Lidia Tarone, Valeria Rolih, et al.. (2019). Cancer stem cell immunology and immunotherapy: Harnessing the immune system against cancer's source. Progress in molecular biology and translational science. 164. 119–188. 39 indexed citations
14.
Donofrío, Gaetano, Stefania Lanzardo, Roberto Ruiu, et al.. (2018). Bovine herpesvirus 4-based vector delivering the full length xCT DNA efficiently protects mice from mammary cancer metastases by targeting cancer stem cells. OncoImmunology. 7(12). e1494108–e1494108. 33 indexed citations
15.
Ruiu, Roberto, Valeria Rolih, Elisabetta Bolli, et al.. (2018). Fighting breast cancer stem cells through the immune-targeting of the xCT cystine–glutamate antiporter. Cancer Immunology Immunotherapy. 68(1). 131–141. 43 indexed citations
16.
Lanzardo, Stefania, Laura Conti, Ronald Rooke, et al.. (2015). Immunotargeting of Antigen xCT Attenuates Stem-like Cell Behavior and Metastatic Progression in Breast Cancer. Cancer Research. 76(1). 62–72. 103 indexed citations
17.
Rolih, Valeria, Elena Quaglino, Valentina Franceschi, et al.. (2015). Bovine herpesvirus 4-based vector delivering a hybrid rat/human HER-2 oncoantigen efficiently protects mice from autochthonous Her-2+mammary cancer. OncoImmunology. 5(3). e1082705–e1082705. 9 indexed citations
18.
Riganti, Chiara, Elisabetta Bolli, Dimas Carolina Belisario, et al.. (2011). Atorvastatin modulates anti-proliferative and pro-proliferative signals in Her2/neu-positive mammary cancer. Biochemical Pharmacology. 82(9). 1079–1089. 10 indexed citations
19.
Petrelli, Dezemona, Elisabetta Bolli, Maurizio Falconi, et al.. (2011). A study on erm(B)-mediated MLS resistance in Streptococcus pyogenes clinical isolates. Diagnostic Microbiology and Infectious Disease. 70(3). 387–394. 1 indexed citations
20.
Napolioni, Valerio, et al.. (2008). Unfaithful association of FCGR2B genetic polymorphisms with susceptibility to SLE. Autoimmunity. 42(2). 139–142. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Valeria Rolih Breakdown of academic impact, for papers by Cathrine Lund Lorentzen Breakdown of academic impact, for papers by Haruka Nishida Breakdown of academic impact, for papers by Ramziya Kiyamova Breakdown of academic impact, for papers by Joseph O. Humtsoe Breakdown of academic impact, for papers by Г. И. Дейчман Breakdown of academic impact, for papers by Wenhao Shen Breakdown of academic impact, for papers by Jia You Breakdown of academic impact, for papers by Sam H. Whiting Breakdown of academic impact, for papers by Masahiro Nobuhara
Rankless by CCL
2026